Technologically Advanced Cardiac Rehabilitation Products to Favor Cardiac Rehabilitation Market Growth During 2021–2028
According to our new research study on “Cardiac Rehabilitation Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Product, Application, and End User,” the market is expected to reach US$ 2,865.42 million by 2028 from US$ 1,780.98 million in 2020; it is estimated to grow at a CAGR of 6.2% from 2021 to 2028. The report highlights major market drivers and prominent companies along with their key developments in the market.
Cardiac rehab is implemented in an outpatient clinic or hospital rehab center. The cardiac rehab team contains nurses, doctors, exercise specialists, physical and occupational therapists, dieticians or nutritionists, and mental health specialists. A few rehabilitation programs include an electrocardiogram, bike exercise, treadmill exercise, and cardiac imaging tests. Patients can also measure their cholesterol and blood sugar levels, which are indicative of heart malfunctions.
Several manufacturers are working on advanced cardiac rehabilitation products. For instance, in July 2018, the US Food and Drug Administration (FDA) has approved the PocketECG Cardiac Rehabilitation System (CRS) developed by MedicAlgorithmics U.S., subsidiary of Medi-Lynx Cardiac Monitoring LLC. The new mobile cardiac rehabilitation system is intended to offer the latest ECG monitoring and automated arrhythmia detection.
Similarly, in April 2019, Royal Philips launched an ultrasonic system EPIQ CVx to offer excellent image clarity and sharpness, upgraded exam efficiencies, as well as more robust and reproducible quantification enabled by anatomical intelligence along with extraordinary processing power.
Geographically, the cardiac rehabilitation market is segmented into North America, Europe, Asia Pacific (APAC), the Middle East and Africa (MEA), and South and Central America (SCAM). North America held the largest market share in 2020. In North America, the US is the largest market for cardiac rehabilitation. The market growth in the region is attributed to the presence of key market players and their engagement in product developments. In addition, growing product launches, surging geriatric population, increasing prevalence of CVDs, and rising adoption of rehabilitation programs are among the prominent factors propelling the market growth in North America.
Halma plc; OMRON Corporation; AVECINNA; Koninklijke Philips N.V.; General Electric Company; Core Health & Fitness, LLC; Peloton Interactive, Inc.; Resideo Technologies, Inc, ergoline GmbH, and HealthCare International are among the leading companies operating in the cardiac rehabilitation market.
The report analyzes cardiac rehabilitation market on the basis of following segments:
Cardiac Rehabilitation Market, by Product
- Treadmill
- Elliptical Trainer
- Stationary Bicycle
- Blood Pressure Monitor
- Rower
- Heart Rate Monitor
- Stabilization Balls
- Others
Cardiac Rehabilitation Market, by Application
- Angioplasty
- Coronary Artery Disease
- Cardiomyopathy
- Cholesterol Management
- Diabetes
- Lung Transplant
Cardiac Rehabilitation Market, by End User
- Cardiac Rehabilitation Centers
- Home Healthcare
- Specialty Hospitals
- Hospitals
- Others
Cardiac Rehabilitation Market, by Geography
- North America
- Europe
- France
- Germany
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific (APAC)
- China
- India
- Japan
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East and Africa (MEA)
- Saudi Arabia
- UAE
- South Africa
- Rest of Middle East and Africa
- South and Central America (SCAM)
- Brazil
- Argentina
- Rest of South and Central America
Contact UsContact Person: Sameer JoshiPhone: +1-646-491-9876Email Id: sales@reportsweb.com
